In the U.S., clinical trials for amyotrophic lateral sclerosis (ALS) do not include enough non-white patients and women to…
Articles by Margarida Maia, PhD
Partially lowering levels of the protein RAD23A can help nerve cells better handle toxic TDP-43 protein clumps, improving survival and…
Tanabe Pharma plans to establish a new U.S.-based company to hold the global rights to Radicava and Radicava…
Both people living with amyotrophic lateral sclerosis (ALS) and their caregivers benefit most from flexible, personalized psychological support that…
QRL-101, an experimental oral small molecule being developed by Quralis for amyotrophic lateral sclerosis (ALS), was found in…
Throughout 2025, ALS News Today delivered readers timely reporting on research breakthroughs, patient advocacy, potential treatments, and diagnostic advances…
Actor Eric Dane, who is living with amyotrophic lateral sclerosis (ALS), has joined the board of directors of…
Actor Eric Dane is teaming up with Target ALS on a campaign to raise $500,000 by Dec. 31 to…
The U.S. Food and Drug Administration (FDA) has authorized Neurosense Therapeutics to begin a pivotal Phase 3 trial of…
Combining two blood biomarkers may make the diagnosis of amyotrophic lateral sclerosis (ALS) more accurate and help predict how…